Metahistine D Interactions
There are 550 drugs known to interact with Metahistine D (pheniramine / phenylpropanolamine / phenyltoloxamine / pyrilamine), along with 12 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 56 are major, 490 are moderate, and 4 are minor.
- View all 550 medications that may interact with Metahistine D
- View Metahistine D alcohol/food interactions (4)
- View Metahistine D disease interactions (12)
Most frequently checked interactions
View interaction reports for Metahistine D (pheniramine / phenylpropanolamine / phenyltoloxamine / pyrilamine) and the medicines listed below.
- atorvastatin
- atorvastatin
- bisacodyl
- bisacodyl
- candesartan
- candesartan
- Carbatrol (carbamazepine)
- Carbatrol (carbamazepine)
- Cardura (doxazosin)
- Cardura (doxazosin)
- Cymbalta (duloxetine)
- Cymbalta (duloxetine)
- Dermol HC (hydrocortisone topical)
- Dermol HC (hydrocortisone topical)
- diltiazem
- diltiazem
- doxazosin
- doxazosin
- Emgality (galcanezumab)
- Emgality (galcanezumab)
- ethaverine
- ethaverine
- fluoxetine
- fluoxetine
- folic acid
- folic acid
- furosemide
- furosemide
- indapamide
- indapamide
Metahistine D alcohol/food interactions
There are 4 alcohol/food interactions with Metahistine D (pheniramine / phenylpropanolamine / phenyltoloxamine / pyrilamine).
Metahistine D disease interactions
There are 12 disease interactions with Metahistine D (pheniramine / phenylpropanolamine / phenyltoloxamine / pyrilamine) which include:
- depression
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- psychosis
- BPH
- diabetes
- glaucoma
More about Metahistine D (pheniramine / phenylpropanolamine / phenyltoloxamine / pyrilamine)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.